Congresos Novedades

SOFARCHI – 2023 LECTURES AND SYMPOSIA

Lugar / Place: Universidad Católica de Norte. Sede Antofagasta – Av. Angamos 610

Fecha / Date: 04 al 07 diciembre de 2023

Conferencias / Lectures

Dr. Luis G. Aguayo. Departamento de Fisiología de la Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile. Effects of ethanol on inhibitory neurotransmission in the brain.

Dra. Coralia Rivas. Departamento de Fisiopatología de la Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile. Vitamin C in cancer disease: where are we 50 years later?

Dr. Alexis Kalergis. Millennium Institute Immunology and Immunotherapy, FOCIS Center of Excellence, Pontificia Universidad Católica de Chile, Santiago, Chile. The scientific basis for vaccine efficacy and the immunity controlling the COVID-19 pandemic.

Dra. Concepción Peiró Vallejo. Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España. NLRP3 inflammasome as a vascular pharmacological target: from endothelial senescence to COVID-19.

Dr. Ventura Simonovich. President Asociación Argentina de Farmacología Experimental. Farmacólogo Clínico, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. First Time Studies in Humans: Experience of the Clinical Pharmacology Section.

Dr. David Brayden. School of Veterinary Medicine, University College Dublin, Ireland. The administration of peptides by the oral route: have we made any progress in the last 30 years?.

Dr. Marco Aurélio Martins. President Sociedade Brasileira de Farmacologia e Terapêutica Experimental. Senior Researcher, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Searching and pharmacological profiling of novel candidates for treating asthma.

Simposios / Symposia

The ABC of South American Pharmacology: Argentina / Brasil / Chile. Chair: Dr. Guillermo Díaz Araya.

Young Researchers Universidad de Antofagasta. Chair: Dr. Rodrigo Iturriaga

  • Dr. David Andrade. Exercise Applied Physiology Lab., Centro de investigación en Fisiología y Medicina de Altura (FIMEDALT), Departamento Biomédico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta, Chile. Peripheral chemoreceptors as metabolic sensors at rest and during physical exercise: findings from an experimental model.
  • Dr. Héctor Zapata-Carmona. Laboratorio de Biología de la Reproducción, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta, Chile. Use of pharmacological inhibitors in the interaction between Protein Kinase A and the Ubiquitin Proteasome System in human spermatozoa: A key player in male fertility.
  • Dra. Rafaella Zarate. Instituto Antofagasta, Universidad de Antofagasta, Antofagasta, Chile. Exploring the Impact of Early Serotonergic System Manipulations in Parkinson’s Disease: Insights from Drosophila melanogaster.

Drug Delivery Strategies to Overcome Biological Barriers. Chair: Dr. Javier O. Morales.

  • Dr. Felipe Oyarzún. Departamento de Ciencias y Tecnología Farmacéuticas, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile. Encapsulation methodologies for active molecules to improve their biological potential.
  • Dra. Tania F. Bahamóndez. Escuela de Química y Farmacia, Facultad de Farmacia, Universidad de Valparaíso, Valparaíso, Chile. Drug delivery strategies in biofilm infections.
  • Dr. Wai-Houng Chou. Departamento de Ciencias Farmacéuticas, Universidad Católica del Norte, Antofagasta, Chile. Enhanced buccal permeation through novel peptide-functionalized lipid-core micelles.
  • Dr. Javier O. Morales. Departamento de Ciencias y Tecnología Farmacéuticas, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile. Alternative routes of administration for novel drug delivery systems.

Novel Therapeutics Target in Cardiovascular Diseases. Chair: Dr. Sergio Lavandero

  • Dr. Carlos Sánchez-Ferrer. Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España. Cardiometabolic diseases and vascular dysfunction: in search of pharmacological targets.
  • Dr. Carlos Hermenegildo Caudevilla. Departamento de Fisiología, Facultad de Medicina, Universidad de Valencia, Valencia, España. Exploring miRNAs as Targets in Myocardial Infarction: Unraveling the Interplay of Sex and Aging.
  • Dr. Óscar Lorenzo González. IIS-Fundación Jiménez Díaz, Autónoma University, Madrid & Biomedical Research Network on Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III National Health Institute, Madrid, Spain. Cardiac failure under diabetes and obesity; Do we have pharmacological targets in the mitochondria?.
  • Dr. Sergio Lavandero González. Advanced Center for Chronic Diseases (ACCDiS), Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, University of Chile, Santiago, Chile & Cardiology Division, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Pharmacological Targets in Heart Failure with Preserved Ejection Fraction (HFpEF).

Northern Chile as source of novel bioactive molecules. Chair: Dr. Wai-Houng Chou

  • Dr. Gabino Garrido. Departamento de Ciencias Farmacéuticas, Universidad Católica del Norte, Antofagasta, Chile. Fruit waste from the Atacama Desert as a source of obtaining antioxidant and hypoglycemic extracts.
  • Dr. Adrián Paredes. Departamento de Química, Universidad de Antofagasta, Chile. High Andean flora, a source of new molecules with potential biological activity.
  • Dra. Martha Hengst López. Departamento de Ciencias Farmacéuticas, Universidad Católica del Norte, Antofagasta, Chile. Environmental microbiome of Atacama: a huge biotechnological potential for the pharmaceutical industry.

Novel Pharmacological approaches for studying metabolism in brain tissue. Chair: Dr. Mario Herrera-Marschitz

  • Dr. Mario Herrera-Marschitz. Molecular and Clinical Pharmacology Program, Instituto de Ciencias Biomédicas (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile. Introductory remarks: Pharmacologically induced NAD+ replacement reverses mitochondrial dysfunction and recues from the long-term metabolic deficits induced by perinatal asphyxia.
  • Dra. Romana Schirhagl. University of Groningen, Groningen, The Netherlands. Quantum sensing for free radical generation inb living cells and tissues.
  • Dr. Felix Urra. Molecular and Clinical Pharmacology Program, Instituto de Ciencias Biomédicas (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile. SeaHorse technology for monitoring In Vivo mitochondrial function: A new pharmacological strategy.
  • Dr. Jose Inzunza. Karolinska University Hospital Huddinge, Stockholm, Sweden. Human Brain Organoids as an In Vitro Model System of Neurodegenerative Diseases.

Substance abuse disorders: insights into its mechanisms and potential treatment strategies. Chair: Dr. Mario Rivera-Meza.

  • Dr. Gaetano Di Chiara. University of Cagliari, Cagliari, Italy. Dopamine revisited 50 years later.
  • Dr. Eduardo Karahanian. Universidad Autónoma de Chile, Santiago, Chile. A new drug that decreases both alcohol consumption and ethanol-induced neuroinflammation.
  • Dr. Mario Rivera-Meza. Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile. Activators of ALDH2 as a new type of pharmacologic agents for the treatment of alcohol and nicotine-use disorders.
  • Dr. Rainer Spanagel. University of Heidelberg, Mannheim, Germany. Are psychedelics the magic bullet to treat addiction?.

Bridging the Gap: Where (Bio/Chemo/Pharma)informatics meets Pharmacology. Chair: Dr. David Ramírez

  • Dra. Wendy González Díaz. Centro de Bioinformática, Simulación y Modelado (CBSM), Universidad de Talca, Talca, Chile. Ion channels polypharmacology.
  • Dr. Miguel Reyes-Parada. Centro de Investigación Biomédica y Aplicada, Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile. Binding sites similarities, as the basis for the search of novel polypharmacological drugs.
  • Dr. Carlos Lagos. Escuela de Química y Farmacia, Universidad San Sebastián, Santiago, Chile. Combining shape, electrostatics and fast virtual screening to discover allosteric modulators of the Mineralocorticoid Receptor.
  • Dr. David Ramírez. Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile. Network Pharmacology: New tools to understand how drugs work.

Repositioning Drugs: Novel Pharmacological Approaches for Challenging Diseases. Chair: Dr. Alfredo Molina Berríos

  • Dr. Alfredo Molina Berríos. Laboratory of Pharmacology for the development of Antineoplastic and Antifungal Drugs, Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, University of Chile, Santiago, Chile. Non-steroidal anti-inflammatory drugs (NSAID) as antibiofilm agents against Candida albicans.
  • Dr. José A. Jara. Laboratory of Pharmacology for the development of Antineoplastic and Antifungal Drugs, Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, University of Chile, Santiago, Chile. Repositioning of itraconazole and hydroxychloroquine in the treatment of cancer.
  • Dr. Juan Diego Maya. Molecular and Clinical Pharmacology Program, Instituto de Ciencias Biomédicas (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile. Use of statins as modulating agents of inflammation in chronic Chagas disease.